Synovial expression of vasoactive intestinal peptide in polymyalgia rheumatica

Clinical and Experimental Rheumatology

Volumn 24, Issue 5, 2006, Pages 562-566

  Pulsatelli, Lia ^a   Dolzani, Paolo ^a   Silvestri, Tania ^a   De Giorgio, Roberto ^b   Salvarani, Carlo ^c   Macchioni, Pierluigi ^c   Frizziero, Luigi ^d   Meliconi, Riccardo ^b,e  

^a Laboratorio di Immunologia e Genetica   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Unita Operativa di Reumatologia   (Italy)

^d MAGGIORE HOSPITAL   (Italy)

^e Modulo di Reumatologia   (Italy)

Author keywords

Neuropeptides; Polymyalgia rheumatica; Synovial membrane; Vasoactive intestinal peptide

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CORTICOSTEROID; NEUROPEPTIDE; PREDNISONE; SOMATOSTATIN; STEROID; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; JOINT BIOPSY; MALE; MUSCULOSKELETAL DISEASE; OSTEOARTHRITIS; PATHOPHYSIOLOGY; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID LEVEL; SYNOVITIS;

AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; BIOPSY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; OSTEOARTHRITIS; POLYMYALGIA RHEUMATICA; PREDNISONE; SHOULDER JOINT; SYNOVIAL MEMBRANE; SYNOVITIS; VASOACTIVE INTESTINAL PEPTIDE;

EID: 33845481242     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. SALVARANI C, CANTTNI F. BOIARDI L, HUNDER GG: Polymyalgia reumatica and giant-cell arteritis. N Engl J Med 2002; 347: 261-71.
2. MELICONI R, PULSATELLI L, UGUCCIONI M et al.: Leukocyte infiltration in synovial tissue from the shoulder of patients with polymyalgia rheumatica. Quantitative analysis and influence of corticosteroid treatment. Arthritis Rheum 1996; 39: 1199-207.
3. SALVARANI C, CANTINI F, OLIVIERI I et al.: Proximal bursitis in active polymyalgia reumatica. Ann Intern Med 1997; 127: 27-31.
4. KONTTINEN YT, KEMPPINEN P, SEGERBERG M et al.: Peripheral and spinal neural mechanisms in arthritis, with particular reference to treatment of inflammation and pain. Arthritis Rheum 1994; 37: 965-82.
5. TAKEBA Y, SUZUKI N, KANEKO A, ASAI T, SAKANE T: Evidence for neural regulation of inflammatory synovial cell functions by secreting calcitonin gene-related peptide and vasoactive intestinal peptide in patients with rheumatoid arthritis. Arthritis Rheum 1999; 42: 2418-29.
6. HOOD VC, CRUWYS SC, URBAN L, KIDD BL: The neurogenic contribution to synovial leucocyte infiltration and other outcome measures in a guinea pig model of arthritis. Neurosci Lett 2001; 299: 201-4.
7. HEALEY LA: Long-term follow-up of polymyalgia rheumatica: evidence for synovitis. Semin Arthritis Rheum 1984; 13: 322-8.
8. ALTMAN R, ASCH E, BLOCH D et al.: Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthrifis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986; 29: 1039-49.
9. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
10. WONG HC, STERNINI C, LLOYD K, DE GIORGIO R, WALSH JH: Monoclonal antibody to VIP: production, characterization, immunoneutralizing activity, and usefulness in cytochemical staining. Hybridoma 1996; 15: 133-9.
11. DELGADO M, POZO D, GANEA D: The significance of vasoactive intestinal peptide in immunomodulation. Pharmacol Rev 2004; 56: 249-90.
12. MILLAN MJ: The induction of pain: an integrative review. Prog Neurobiol 1999; 57: 1-164.
13. DICKINSON T, FLEETWOOD-WALKER SM: VIP and PACAP: very important in pain? Trends Pharmacol Sci 1999; 20: 324-9.
14. DI SEBASTIANO P, FINK T, DIi MOLA FF et al.: Neuroimmune appendicitis. Lancet 1999; 354: 461-6.
15. DELGADO M, ABAD C, MARTÍNEZ C, LACETA J, GOMARIZ RP: Vasoactive intestinal peptide prevents experimental arthritis by downregulation both autoimmune and inflammatory components of the disease. Nature Med 2001; 7: 563-8.
16. DELGADO M: VIP: a very important peptide in T helper differentiation. Trends Immunol 2003; 24: 221-24.
17. WEYAND CM, HICOK KC, HUNDER GG, GORONZY JJ: Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis. Ann Intern Med 1994; 121: 484-91.
18. GONZALES-GAY MA, HAMER AH, DABABNEH A et al.: Interferon-gamma gene micro-satellite poymorphisms in patients with biopsy-proven giant cell arteritis and isolated polymyalgia rheumatica. Clin Exp Rheumatol 2004; 22: S18-S20.
19. CHORNY A, GONZALES-REY E, FERNANDEZ-MARTIN A, POZO D, GANEA D, DELGADO M: Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders. PNAS 2005; 102: 1362-7.
20. GONZALES-REY E, FERNANDEZ-MARTIN A, CHORNY A, DELGADO M: Vasoactive intestinal peptide induces CD4+,CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis. Arthritis Rheum 2006; 54: 864-76.
21. WEYAND CM, MA-KRUPA W, GORONZY JJ: Immunopathways in giant cell arteritis and polymyalgia rheumatica. Autoimmun Rev 2004; 3: 46-53.